Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01699698 · ClinicalTrials.gov registry record · NA
Pancreatic Juice Diagnosis From Duodenum
A NA study, sponsored by Olympus Corporation.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT01699698 is a NA study that has completed, run by Olympus Corporation. The registered enrollment target is 105 participants.
The verdict
NCT01699698, a NA study, has completed, sponsored by Olympus Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
Purpose of this study is to understand the clinical feasibility of duodenal juice diagnosis to screen UICC stage II pancreatic ductal adenocarcinoma patients.
Interventions
- OTHER Tumor markers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01699698
The ClinicalTrials.gov registry entry for NCT01699698 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olympus Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tumor markers is the first listed.
NCT01699698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01699698 about?
NCT01699698 is a clinical study titled "Pancreatic Juice Diagnosis From Duodenum". Purpose of this study is to understand the clinical feasibility of duodenal juice diagnosis to screen UICC stage II pancreatic ductal adenocarcinoma patients.
What is the current status of trial NCT01699698?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2012-10.
What interventions are being tested in trial NCT01699698?
The interventions under investigation include: Tumor markers (OTHER).
Who is sponsoring clinical trial NCT01699698?
This trial is sponsored by Olympus Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.